Select your country

Africa
Asia
Europe
Latin America
North America
Oceania

Acquisitions & Divestments

The list below offers extensive information about our past acquisitions and divestments.


Acquisitions

Name of Company
Transaction costs
Year Business Sector
Press Release
BioControl
n/a 2017 Life Science
Further information
Sigma-Aldrich
€ 13.1 bn
2015 Life Science
Further information
Ormet Circuits
n/a 2015 Performance Materials
Further information
Qlight Nanotech
n/a
2015 Performance Materials
Further information
Peer+
n/a 2014 Performance Materials
Further information
AZ Electronics
€ 1.9 bn
2014 Performance Materials
Further information
Biochrom AG
n/a
2012 Life Science
Further information
CellASIC (USA)
n/a 2012 Life Science
n/a
Amnis (USA)
n/a
2011 Life Science
Further information
heipha Dr. Müller GmbH/Hycon branch of Biotest AG
n/a
2011 Life Science
Further information
Beijing Skywing Technology (China)
€ 14.5 m
2010 Life Science
Further information
Millipore Corporation (US)
€ 5.1 bn
2010 Life Science
Further information
Taizhu (China)
€ 26.3 m
2009 Performance Materials
Further information
Bio-Fyt Pharma (Belgium)
€ 30.0 m
2008 Healthcare
Further information
SeQuant
€ 6.9 m
2008 Life Science
Further information
Serono (Switzerland)
€ 10.3 bn
2006 Healthcare
Further information
Agribiotics Holdings (Canada)
€ 21.9 m
2006 Performance Materials
n/a
Survac (Denmark)
€ 10.8 m
2005 Healthcare
n/a
OLED and polymer electronics activities from Avecia (UK) incl. Covion (Germany)
€ 49.3 m
2005 Performance Materials
n/a
NM Pharma (Scandinavia)
€ 49,1 m
2004
divested with EMD Generics
n/a
Nature's Best, VMS mail order (UK)
€ 22,8 m
2003 Healthcare
n/a
Laboratoires Richelet (France)
€ 9.3 m
2002 Healthcare
n/a

Divestments

Name of Company
Transaction costs
Year Business
Press Release
Biosimilars Business n/a 2017 Healthcare Further inforamtion
Pakistan Healthcare Business of Merck KGaA, Darmstadt, Germany
n/a 2016 Healthcare
n/a
Discovery and Development Solutions
€ 22.6 m
2015 Life Science
n/a
Mobile Energy Business (Germany)
n/a 2012 Performance Materials
n/a
Crop BioScience Business (USA, Canada & Argentina)
€ 208.2 m
2010 EMD Serono
n/a
Théramex (Monaco & Italien)
€ 269.3 m
2010 EMD Serono n/a
EMD Generics Division
€ 4.9 bn
2007 n/a n/a
ITO/CF Business (Taiwan)
€ 29 m
2006 Performance Materials
n/a
Electronic Chemicals Business
€ 270 m
2005 Performance Materials
n/a
Lab distribution VWR (US)
$ 1.68 bn
2004 n/a n/a
50% holding of Biomet-Merck KGaA, Darmstadt, Germany
$ 300 m
2004 Performance Materials
n/a
Financials
Read More
Financials

Our Financial Reporting Center offers you the opportunity to select from financial data on an annual or quarterly basis.

Webcasts & Presentations
learn more
Webcasts & Presentations

There is a large number of presentations and webcasts of different events available for download. They provide helpful insights into our company, our businesses and executives as well as our financial development.

Analysts & Consensus
Read More
Analysts & Consensus

Several banks and brokerages regularly cover Merck KGaA, Darmstadt, Germany, by publishing analyses, short reviews and updates. An accurate and up to date consensus of these various projections is provided by VARA Research once per quarter.

Redirect

You have accessed emdgroup.com, but for users from your part of the world, we originally designed the following web presence merckgroup.com

Let's go